SUMMARY The products resulting from proteolytic degradation of human fibrinogen (FDP) were found to induce the release of histamine from rat peritoneal mast cells. Low molecular weight, dialysable peptides (FDP) showed the highest dose dependent, histamine releasing activity. Histamine release induced by FDP was effectively inhibited by the gold compound auranofin at a concentration of lo-5_10-7 moUI and also by the non-steroidal anti-inflammatory drugs BW 755c, timegadine, medosan, naproxen, and aspirin at the higher concentration range of 1i0-i_O-6 mol/l. It is concluded that the release of histamine from mast cells may be modulated to some extent by anti-inflammatory drugs, especially auranofin, BW 755c and timegadine, a functional property which may be beneficial in the management of joint disease.
Low molecular weight fibrinogen degradation products (LMW-FDP) derived from plasmin digestion exhibit a variety of biological activities. These peptides inhibit platelet aggregation,' are chemotactic to polymorph neutrophils,2 suppress immunoreactivity,3 damage kidney4 and endothelial cells in culture,5 increase the progression of some experimental tumours,6 and enhance the permeability of capillaries and the blood-brain barrier. 7 The recently reported release of histamine from mast cells by peptides cleaved from fibrinogen may explain their effects on the microvasculature. 8 Interest in the role of mast cells in joint disease has increased since reports of their increased numbers in the rheumatoid synovium,9 "' and their demonstration at sites of cartilage erosion." 12 Indeed, the measurement of histamine in synovial fluids from both rheumatoid and osteoarthritic patients,13 14 (Fig. 2) . The major peaks observed were peak I eluting at the void volume and peaks II and III eluting at approximately 4300 and 1400 daltons respectively. The effect of these fractions on the release of histamine from mast cells is shown in Fig. 3 . Fraction III had a strong histamine releasing potency, whereas fraction I was inactive. Fraction II showed only weak activity and therefore was not studied further. (Fig. 4) . The effects of the anti-inflammatory drugs auranofin, timegadine, medosan, naproxen, BW 755c, and aspirin on the FDP (fraction III) mediated histamine release from mast cells were subsequently examined and are shown in . 1O 20 30 Incubation time (min) 
